ARKMENT Trademark

Trademark Overview


On Wednesday, March 26, 2014, a trademark application was filed for ARKMENT with the United States Patent and Trademark Office. The USPTO has given the ARKMENT trademark a serial number of 79145759. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, March 26, 2024. This trademark is owned by Novartis AG. The ARKMENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
arkment

General Information


Serial Number79145759
Word MarkARKMENT
Filing DateWednesday, March 26, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, March 26, 2024
Registration Number4590930
Registration DateTuesday, August 26, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, May 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 24, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 25, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, April 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 29, 2014ASSIGNED TO EXAMINER
Saturday, May 3, 2014APPLICATION FILING RECEIPT MAILED
Wednesday, May 21, 2014NOTICE OF PUBLICATION
Tuesday, June 10, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 26, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, September 25, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, September 26, 2014FINAL DISPOSITION PROCESSED
Friday, September 26, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 17, 2014NOTIFICATION PROCESSED BY IB
Friday, March 12, 2021CANCELLED SECTION 71
Friday, November 12, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 18, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, May 23, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, April 1, 2022INVALIDATION PROCESSED
Friday, April 1, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB